What antibiotics are recommended for treating streptococcal (strep) pharyngitis in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Strep Pharyngitis in India

Penicillin V or amoxicillin should be used as first-line treatment for streptococcal pharyngitis in India, with a 10-day course being essential to prevent rheumatic fever, which remains a significant concern in the region. 1, 2

First-Line Treatment Options

Oral Options:

  • Penicillin V:

    • Children: 250 mg two or three times daily for 10 days
    • Adolescents and adults: 250 mg four times daily or 500 mg twice daily for 10 days 1
  • Amoxicillin (often preferred due to better taste and compliance):

    • 50 mg/kg once daily (maximum 1,000 mg) for 10 days
    • Alternative: 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 1, 2

Parenteral Option:

  • Benzathine Penicillin G (single intramuscular injection):
    • <60 lb (27 kg): 600,000 units
    • ≥60 lb (27 kg): 1,200,000 units 1

Second-Line Treatment Options (for penicillin-allergic patients)

Non-anaphylactic Penicillin Allergy:

  • First-generation cephalosporins (e.g., cephalexin):
    • 20 mg/kg twice daily (maximum 500 mg per dose) for 10 days 1

Immediate-type/Severe Penicillin Allergy:

  • Clindamycin:

    • 7 mg/kg three times daily (maximum 300 mg per dose) for 10 days 1
  • Clarithromycin:

    • 7.5 mg/kg twice daily (maximum 250 mg per dose) for 10 days 1
  • Azithromycin:

    • 12 mg/kg once daily (maximum 500 mg) for 5 days 1
    • Note: Azithromycin has shown lower bacteriological eradication rates compared to penicillin (38% vs 81%) despite similar clinical success rates 3

Important Considerations for India

  1. Complete the full course: The 10-day duration for penicillin/amoxicillin is critical in India where rheumatic fever remains a significant concern 1, 2

  2. Antimicrobial resistance: While penicillin resistance in Group A Streptococcus has not been documented worldwide, macrolide resistance varies geographically 1

  3. Avoid tetracyclines and sulfonamides: These have higher resistance rates among Group A streptococci and frequently fail to eradicate even susceptible organisms 1

  4. Diagnostic confirmation: Whenever possible, confirm diagnosis with rapid antigen detection test or throat culture before initiating antibiotics 2

Treatment Algorithm

  1. Confirm diagnosis using clinical criteria (Centor criteria) and laboratory testing when available
  2. For non-allergic patients: Start penicillin V or amoxicillin for 10 days
  3. For penicillin-allergic patients:
    • Non-anaphylactic allergy: First-generation cephalosporins for 10 days
    • Anaphylactic allergy: Clindamycin, clarithromycin, or azithromycin

Pitfalls to Avoid

  1. Shortened treatment duration: While shorter courses (3-5 days) of newer antibiotics like azithromycin are convenient, they may have higher bacteriological failure rates and should be avoided in regions with high rheumatic fever prevalence 4

  2. Overtreatment of viral pharyngitis: Not all sore throats require antibiotics; clinical scoring systems help identify patients likely to have streptococcal infection 2

  3. Inadequate follow-up: While routine post-treatment testing is not recommended, patients should return if symptoms worsen or fail to improve within 48-72 hours 2

  4. Treating carriers: Asymptomatic carriers generally don't require treatment unless specific risk factors exist 1

By following these evidence-based recommendations, clinicians in India can effectively treat streptococcal pharyngitis while minimizing complications and antibiotic resistance.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Pharyngitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.